CA3001572A1 - Enteral feeding devices and related methods of use - Google Patents

Enteral feeding devices and related methods of use Download PDF

Info

Publication number
CA3001572A1
CA3001572A1 CA3001572A CA3001572A CA3001572A1 CA 3001572 A1 CA3001572 A1 CA 3001572A1 CA 3001572 A CA3001572 A CA 3001572A CA 3001572 A CA3001572 A CA 3001572A CA 3001572 A1 CA3001572 A1 CA 3001572A1
Authority
CA
Canada
Prior art keywords
particles
nutritional formula
chamber
lipase
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3001572A
Other languages
English (en)
French (fr)
Inventor
Robert Gallotto
Greta L. Loring
Kenneth Gary
Edward S. Park
David J. Brown
Willem Robert Klaas Schoevaart
Michiel Christian Alexander Van Vliet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcresta Therapeutics Inc
Original Assignee
Alcresta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcresta Therapeutics Inc filed Critical Alcresta Therapeutics Inc
Publication of CA3001572A1 publication Critical patent/CA3001572A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0003—Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0015—Gastrostomy feeding-tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/0076—Feeding pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/044—Proteins; Polypeptides; Degradation products thereof
    • A61L29/048—Other specific proteins or polypeptides not covered by A61L29/045 - A61L29/047
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1413—Modular systems comprising interconnecting elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08—Tubes; Storage means specially adapted therefor
    • A61M2039/085—Tubes; Storage means specially adapted therefor external enteral feeding tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0482—Enteral feeding product

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA3001572A 2015-10-14 2016-10-13 Enteral feeding devices and related methods of use Pending CA3001572A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562241608P 2015-10-14 2015-10-14
US62/241,608 2015-10-14
US15/291,530 2016-10-12
US15/291,530 US10258590B2 (en) 2015-10-14 2016-10-12 Enteral feeding device and related methods of use
PCT/US2016/056722 WO2017066372A1 (en) 2015-10-14 2016-10-13 Enteral feeding devices and related methods of use

Publications (1)

Publication Number Publication Date
CA3001572A1 true CA3001572A1 (en) 2017-04-20

Family

ID=57227095

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3001572A Pending CA3001572A1 (en) 2015-10-14 2016-10-13 Enteral feeding devices and related methods of use

Country Status (14)

Country Link
US (4) US10258590B2 (enExample)
EP (2) EP3362084B1 (enExample)
JP (3) JP6830668B2 (enExample)
KR (3) KR102831837B1 (enExample)
CN (1) CN108391421A (enExample)
AU (3) AU2016339039B2 (enExample)
CA (1) CA3001572A1 (enExample)
DK (1) DK3362084T3 (enExample)
ES (1) ES3010654T3 (enExample)
IL (3) IL258566B (enExample)
MX (2) MX391089B (enExample)
PL (1) PL3362084T3 (enExample)
WO (1) WO2017066372A1 (enExample)
ZA (2) ZA201802505B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
WO2018129432A1 (en) * 2017-01-09 2018-07-12 Turner R Scott Valve for a fluid flow assembly
US11045396B2 (en) * 2017-08-17 2021-06-29 Alcresta Therapeutics, Inc. Devices and methods for the supplementation of a nutritional formula
US20190075835A1 (en) * 2017-09-08 2019-03-14 Alcresta Therapeutics, Inc. Devices and methods for preparing and administering a nutritional formula
US11291236B2 (en) * 2017-09-11 2022-04-05 Alcresta Therapeutics, Inc. Devices and methods for the preparation of a nutritional formula
CA3107054A1 (en) * 2018-07-24 2020-01-30 Atr Thrive, Llc Compositions of lipases and pregastric esterases for mammalia nutrition support
US11344480B2 (en) 2018-07-26 2022-05-31 Medline Industries, Lp Enteral fluid delivery system
ES2841807T5 (en) * 2018-11-30 2026-06-30 Klaus Stegemann A sterile solution with an application injector comprising a medical agent and method for producing same
AU2019410752B2 (en) * 2018-12-21 2025-06-26 Société des Produits Nestlé S.A. Enteral nutrition container cap and methods of making and using the cap
US10765798B2 (en) 2019-01-24 2020-09-08 Medline Industries, Inc. Feeding syringe holder
USD920504S1 (en) 2019-07-01 2021-05-25 Medline Industries, Inc. Valve
USD906516S1 (en) 2019-07-01 2020-12-29 Medline Industries, Inc. Valve clip
US11110036B2 (en) * 2019-07-01 2021-09-07 Medline Industries, Inc. Feeding set and enteral feeding pump assembly
CN110632067B (zh) * 2019-10-29 2021-12-24 中国计量大学 基于机器视觉的水体溶解氧检测方法
WO2021161723A1 (ja) * 2020-02-14 2021-08-19 株式会社日立ハイテク 自動分析装置
JP7057004B1 (ja) 2021-03-05 2022-04-19 国立大学法人東京工業大学 予測装置、学習済みモデルの生成装置、予測方法、学習済みモデルの生成方法、予測プログラム、及び学習済みモデルの生成プログラム
US12419720B2 (en) 2021-04-26 2025-09-23 Springloc Ltd. Multimodality ID markers for delineating the position of a region of interest (ROI) within a body
US12402976B2 (en) 2021-04-26 2025-09-02 Springloc Ltd Augmented reality soft tissue biopsy and surgery system
CN116268114A (zh) * 2023-03-27 2023-06-23 江南大学 一种油脂组合物及其制备方法和应用
WO2025122937A1 (en) * 2023-12-08 2025-06-12 The Cleveland Clinic Foundation Micronutrient compositions and systems for treating malnutrition and preventing refeeding syndrome
US20260009057A1 (en) 2024-07-05 2026-01-08 Alcresta Therapeutics, Inc. Methods and devices for hydrolyzing fats

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2807384A (en) 1956-03-12 1957-09-24 Lipari Michael Compartmental dispensing receptacle
US3838784A (en) 1973-04-12 1974-10-01 Mead Johnson & Co Diet feeding container
US4225575A (en) 1978-05-15 1980-09-30 Ventrex Laboratories, Inc. Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
JPS54132291A (en) 1978-04-03 1979-10-15 Kuraray Co Ltd Novel bioreactor
US5212143A (en) * 1978-08-28 1993-05-18 Torobin Leonard B Hollow porous microspheres made from dispersed particle compositions
DE2935546C2 (de) 1979-09-03 1983-05-11 Lepharm- Pharmazeutische Entwicklungs- und Vertriebsgesellschaft mbH, 5000 Köln Diätetische Lebensmittel mit Monoglyceriden von Fettsäuren
US5292649A (en) 1983-03-29 1994-03-08 Agency Of Industrial Science & Technology, Ministy Of International Trade & Industry Method for reaction of lipase upon fatty acid
JPS6027380A (ja) 1983-07-25 1985-02-12 Nitto Electric Ind Co Ltd 酵素反応装置
US4637934A (en) 1984-04-12 1987-01-20 Baxter Travenol Laboratories, Inc. Liquid container with integral opening apparatus
US4629742A (en) * 1986-01-27 1986-12-16 Akzo America Inc. Hydrolysis of fats
JPH0787793B2 (ja) 1986-10-22 1995-09-27 日本油脂株式会社 高度不飽和脂肪酸の分離方法
JP2641935B2 (ja) 1987-09-28 1997-08-20 ノボ‐ノルディスク アクティーゼルスカブ リパーゼの固定化方法
JPH0198494A (ja) 1987-10-09 1989-04-17 Agency Of Ind Science & Technol バイオリアクター
US4944944A (en) 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
JP2581749B2 (ja) 1988-04-27 1997-02-12 株式会社資生堂 固定化酵素を用いた油脂の分解槽およびこの分解槽を用いた油脂の分解装置並びに油脂の分解方法
US5922345A (en) 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5453270A (en) 1992-03-30 1995-09-26 Hypermetabolic Therapies, Inc. Pharmaceutical composition and method for hypermetabolic weight loss
US5902617A (en) 1992-05-19 1999-05-11 Pabst; Patrea L. Enzyme supplemented baby formula
US5259587A (en) 1992-06-08 1993-11-09 Whitman Medical Corporation Roller clamp
US5342790A (en) 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
FI930440A0 (fi) 1993-02-01 1993-02-01 Labsystems Oy Bestaemningsfoerfarande
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
JPH08178926A (ja) 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5533973A (en) 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5531681A (en) 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531734A (en) 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
FR2731015B1 (fr) 1995-02-24 1997-05-30 Sci Sartone Procede d'enrichissement enzymatique d'huiles d'origine marine et les triglycerides d'acides gras polyinsatures ainsi obtenus
US5707353A (en) 1995-12-21 1998-01-13 Abbott Laboratories Oral administration of beneficial agents
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
AU764964B2 (en) 1998-11-23 2003-09-04 Usamriid Purification method and apparatus
ES2249868T3 (es) 1999-02-12 2006-04-01 Societe Des Produits Nestle S.A. Composicion liquida estabilizada, procedimento de preparacion y producto nutritivo que la contiene.
JP2002180082A (ja) 2000-12-11 2002-06-26 Maruha Corp 摂取物
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
EP1438378B1 (en) 2001-10-18 2011-10-26 Council of Scientific and Industrial Research Cholesterol lowering structured lipids with omega 6 pufa
IL147942A0 (en) 2002-01-31 2002-08-14 Enzymotec Ltd Method of fractionation of phytosterol esters in oil and products obtained thereby
AU2003252324A1 (en) 2002-08-07 2004-03-11 Kao Corporation Fat composition
JP4268473B2 (ja) 2002-08-07 2009-05-27 花王株式会社 油脂組成物
US7410663B2 (en) 2002-08-07 2008-08-12 Kao Corporation Oil or fat composition
US20040209953A1 (en) 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
JP2004248671A (ja) 2003-01-31 2004-09-09 Rinoru Oil Mills Co Ltd 共役リノール酸異性体の精製方法およびその用途
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
EP1713463A4 (en) 2004-01-19 2009-03-18 Martek Biosciences Corp REELIN LACK OR DYSFUNCTION AND RELEVANT PROCEDURE
EP1720539A4 (en) 2004-02-13 2010-07-21 Martek Biosciences Corp SCHIZOCHYTRIUM FATTY ACID SYNTHASE (FAS) AND RELEVANT PRODUCTS AND METHOD
JP2005224401A (ja) 2004-02-13 2005-08-25 Minoru Fujimoto アルコールの処理方法およびアルコール処理装置
JP2007526943A (ja) 2004-03-04 2007-09-20 エイチティーエル ハイ − テック リピッズ リミテッド 構造化されたトリグリセリド類およびそれを含むエマルション類
JP2005272307A (ja) 2004-03-23 2005-10-06 Dd Planning Kk 抗菌・防カビ・消臭剤の噴霧方法及びその噴霧装置
SE0401145D0 (sv) 2004-04-30 2004-04-30 Mats Malmqvist Continuous flow reaction vessel system
DK1809320T3 (da) 2004-10-14 2010-11-15 Cystic Fibrosis Foundation The Præparater indeholdende lipase, protease og amylase til behandling af pankreatisk insufficiens
GB0504333D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
JP5013679B2 (ja) 2005-04-28 2012-08-29 天野エンザイム株式会社 含油脂廃水処理装置及び含油脂廃水処理方法
US8048652B2 (en) 2005-05-12 2011-11-01 Martek Biosciences Corporation Biomass hydrolysate and uses and production thereof
US7582474B2 (en) * 2005-07-11 2009-09-01 Honeywell International Inc. Process reactor with layered packed bed
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
BRPI0620465A2 (pt) 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
EP2049597B1 (de) 2006-07-26 2010-02-24 Basf Se Thermoplastische formmassen mit hoher steifigkeit
UA97127C2 (uk) 2006-12-06 2012-01-10 Бандж Ойлз, Инк. Спосіб безперервної ферментативної обробки композиції, що містить ліпід, та система для його здійснення
WO2008127567A1 (en) * 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
DE102007031689A1 (de) 2007-07-06 2009-01-08 Evonik Goldschmidt Gmbh Enzympräparate
KR101650584B1 (ko) 2007-08-31 2016-08-23 디에스엠 아이피 어셋츠 비.브이. 다중불포화된 지방산 함유 고체 지방 조성물 및 그의 용도 및 생산
EP2205497A4 (en) 2007-09-06 2012-10-24 Suremilk Llc UNIVERSAL DRINKING ADAPTER FOR DRINKING BOTTLES FOR LIQUID CONSUMPTION AND DEVICES AND DEVICES FOR DETERMINING SMALL MOLECULES, METAL IONS, ENDOTOXINS AND BACTERIA IN MILK, AND METHODS OF USE THEREOF
US8975299B2 (en) 2007-11-01 2015-03-10 Enzymotec Ltd. Lipid mixture for infant nutrition
US8206772B2 (en) 2007-11-08 2012-06-26 Kraft Foods Global Brands Llc Structured lipid compositions and methods of formulation thereof
MY177280A (en) 2008-01-24 2020-09-10 Nestle Sa Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
EP2110027A1 (en) 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
JP2010029114A (ja) 2008-07-29 2010-02-12 Life Time:Kk ペット用ハーネス
US20120279939A1 (en) 2008-10-27 2012-11-08 Lee Jeong-Min Bottle cap
WO2010062678A2 (en) * 2008-10-30 2010-06-03 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
JP5931721B2 (ja) 2009-06-16 2016-06-08 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ アシルＣｏＡリゾリン脂質アシルトランスフェラーゼの発現による長鎖オメガ−３及びオメガ−６多価不飽和脂肪酸生合成の改良
FR2955459B1 (fr) 2010-01-28 2013-11-22 Polaris Composition huileuse riche en monoglycerides de dha
JP5637753B2 (ja) 2010-07-02 2014-12-10 株式会社東芝 溶接狙い位置計測装置
WO2012011877A2 (en) * 2010-07-23 2012-01-26 Curiox Biosystems Pte Ltd Apparatus and method for multiple reactions in small volumes
AR082943A1 (es) 2010-08-06 2013-01-23 Aptalis Pharma Ltd Formula nutricional predigerida
ES2558112T3 (es) 2010-12-29 2016-02-02 Abbott Laboratories Productos nutricionales que incluyen un nuevo sistema lipídico que incluye monoglicéridos
IL313986B1 (en) * 2012-02-17 2026-05-01 Alcresta Inc Methods, compositions and devices for supplying dietary fatty acid needs
GB201216482D0 (en) * 2012-09-14 2012-10-31 Univ Aberystwyth Novel lipases,polynucleotides encoding them and their uses
US9920294B2 (en) * 2013-02-15 2018-03-20 Douglas T. Gjerde Devices and methods for purification, detection and use of biological cells
US20140378419A1 (en) 2013-06-21 2014-12-25 Mead Johnson Nutrition Company Compositions and Methods for Nutrient Delivery
EP3639846B1 (en) 2013-08-09 2022-09-28 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
EP3193814B1 (en) 2014-09-04 2018-08-22 Corpak Medsystems, Inc. Gastric systems, apparatus, and methods for use with enteral feeding
NO20150142A1 (en) 2015-01-30 2016-08-01 Pronova Biopharma Norge As Enteral feeding device
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
US11045396B2 (en) 2017-08-17 2021-06-29 Alcresta Therapeutics, Inc. Devices and methods for the supplementation of a nutritional formula
US11084037B2 (en) * 2017-09-25 2021-08-10 Plexium, Inc. Oligonucleotide encoded chemical libraries

Also Published As

Publication number Publication date
EP4483858A2 (en) 2025-01-01
IL285004B (en) 2022-03-01
JP2021035648A (ja) 2021-03-04
KR102636348B1 (ko) 2024-02-15
WO2017066372A1 (en) 2017-04-20
NZ781021A (en) 2024-07-05
EP4483858A3 (en) 2025-03-26
US20190224155A1 (en) 2019-07-25
JP7042507B2 (ja) 2022-03-28
BR112018007472A2 (en) 2018-10-23
MX391089B (es) 2025-03-04
HK1259022A1 (en) 2019-11-22
AU2023202075A1 (en) 2023-05-04
AU2016339039B2 (en) 2023-01-05
AU2025208578A1 (en) 2025-08-14
MX2018004485A (es) 2018-08-01
US20210283085A1 (en) 2021-09-16
IL258566B (en) 2021-09-30
JP6830668B2 (ja) 2021-02-17
PL3362084T3 (pl) 2025-05-19
US20170105903A1 (en) 2017-04-20
ZA201802505B (en) 2019-12-18
EP3362084A1 (en) 2018-08-22
KR20240024324A (ko) 2024-02-23
MX2022000482A (es) 2022-02-03
DK3362084T3 (da) 2025-02-03
US11045440B2 (en) 2021-06-29
ES3010654T3 (en) 2025-04-04
AU2016339039A1 (en) 2018-05-10
AU2023202075B2 (en) 2025-05-01
US11944596B2 (en) 2024-04-02
US20240156768A1 (en) 2024-05-16
US10258590B2 (en) 2019-04-16
KR20250111225A (ko) 2025-07-22
ZA202103990B (en) 2024-11-27
NZ741561A (en) 2024-03-22
JP2018533399A (ja) 2018-11-15
EP3362084B1 (en) 2024-12-25
IL289823A (en) 2022-03-01
IL285004A (en) 2021-08-31
JP2019217351A (ja) 2019-12-26
IL258566A (en) 2018-05-31
KR102831837B1 (ko) 2025-07-10
CN108391421A (zh) 2018-08-10
US12514839B2 (en) 2026-01-06
KR20180069008A (ko) 2018-06-22
NZ780997A (en) 2024-07-26

Similar Documents

Publication Publication Date Title
AU2023202075B2 (en) Enteral feeding devices and related methods of use
JP7645549B2 (ja) 食餌性脂肪酸の要求を満たすための方法、組成物、及び装置
JP2020531084A (ja) 栄養調合物の補給のためのデバイスおよび方法
JP2026050467A (ja) 栄養調合物の調製のためのデバイスおよび方法
HK40120877A (en) Enteral feeding devices and related methods of use
HK1259022B (en) Enteral feeding devices and related methods of use
JP2022172204A (ja) 栄養処方物を調製および投与するためのデバイスおよび方法
BR112018007472B1 (pt) Dispositivos de alimentação entérica
US20260009057A1 (en) Methods and devices for hydrolyzing fats

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210922

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20240806

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241011

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241011

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241011

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20241203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250203

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250601

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250601

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD

Year of fee payment: 9

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250929

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250929

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260117

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260127

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D11-D131 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR CONTINUED EXAMINATION (RCE) RECEIVED

Effective date: 20260526

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20260526

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D174 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR CONTINUED EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260623

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D148 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR CONTINUED EXAMINATION (NOA/CNOA) DETERMINED COMPLIANT

Effective date: 20260623

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260623

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260623

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260623

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260623